Researchers at NYU’s Langone Medical Center and other institutions have test-driven a new approach to mitigate multiple sclerosis (MS) symptoms, combining transcranial direct current stimulation (tDCS) with cognitive training.
The ethical minefield surrounding the FDA’s compassionate use application process was front page news in 2014. The debate over who gets access to new and experimental treatments when all other options have run out for people with terminal illnesses or debilitating diseases spawned a social media campaign that led to a media firestorm. This led […]
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.